APS will award at least two grants in the amount of $20,000 each to pain research proposals demonstrating the greatest merit and potential for success. Funds will be awarded for an eighteen month grant period that will begin upon satisfactory execution of the grant agreement between APS and the sponsoring institution, and the receipt of IRB/IACUC approval.
The Future Leaders in Pain Research grant program was established in 2005 to fund pain research projects of doctoral-prepared investigators who have not yet attained NIH RO1 level funding. The purpose of this grant is to encourage research in pain that will add to the existing body of knowledge, and to allow investigators to develop pilot data that will aid them in securing additional major grant funding for continued pain research.
To be eligible for an APS Future Leaders in Pain Research Grant, applicants must be an:
Please see the detailed program guidelines for any questions with the application instructions and process.
For additional information, contact APS at 847.375.6332 or apairitz@americanpainsociety.org.
APS Future Leaders in Pain Research Grants Program Review Committee
Patrick M. Dougherty, PhD, Chair
Karen O. Anderson, PhD
Jim Campbell, MD
Michael Caterina, PhD
Robert R. Edwards, MD PhD
Michael Gold, PhD
Janean Holden, PhD RN FAAN
Jianren Mao, MD PhD
Gayle Page, RN DNSc
Barbara Rakel, PhD RN
APS gratefully acknowledges Eli Lilly, Endo Pharmaceuticals Inc., Purdue Pharma L.P. and Teva Pharmaceuticals for their generous funding of the 2012 grants program.